Susan Patel
ID DEMO-004Low Review PriorityLatest assessment 2026-06-14T00:42:34.449893+00:00Messages →Report →Export summary →Decision support only. Consolidates patient data for faster physician review. It does not diagnose, recommend treatment, generate dosing, or replace physician judgment.
Primary phenotype
mitochondrial dysfunction
Recovery stage
stable
Confidence
81/100
high
Clinical improvement
50
functional 50
Phenotype profile
Clinical snapshot
mitochondrial dysfunction81%dysautonomia
Recovery stage (derived): stable — Clinical improvement score 50 (45–55 ≈ no net change).
Top contributors: Fatigue, Post-exertional malaise, Exercise intolerance, Unrefreshing sleep, Muscle weakness
Phenotype engine
All phenotype scores
Co-infection engine
Pattern scores
bartonella0 Low
babesia29 Mild
ebv35 Mild
mold cirs0 Low
mcas0 Low
Lab intelligence
System concern scores
inflammatory0 Low
immune0 Low
mitochondrial20 Low
hormonal0 Low
metabolic0 Low
nutritional0 Low
detoxification0 Low
neuroinflammatory10 Low
connective tissue0 Low
Abnormal: lactate (high), ck (high) · Missing: 39
Safety review
Risk flags
No high or critical flags.
Monitoring: Physician review before protocol selection
Missing: pregnancy_status_confirmed, infection_status_confirmed
Outcomes
Baseline vs current
| Metric | Baseline | Current |
|---|---|---|
| fatigue score | 9 | 9 |
| brain fog score | 6 | 6 |
| pain score | 5 | 5 |
| sleep quality score | 3 | 3 |
| pem score | 9 | 9 |
| work capacity percent | 15 | 15 |
Knowledge
Phenotype-relevant references
Protocol assets: BPC-157TB-500 / TB4KPVLL-37MOTS-cSS-31GHK-CuIpamorelinCJC-1295
Evidence documents: SS-31: Mechanistic Overview (preclinical)MOTS-c: Mechanistic Overview (preclinical)Mitochondrial Dysfunction Phenotype: Background (observational)Synergistic Effects of Monolaurin, Thymosin Alpha-1, KPV, SS-31, MOTS-c, Zinc, Vitamin D3, B12, Folate, Selenium, Magnesium Glycinate, and DGL on Epstein-Barr Virus Reversal in a Murine Gammaherpesvirus 68 (MHV-68) Model.docx (expert_opinion)Synergistic Effects of BPC-157, KPV, Thymosin Alpha-1, GHK-Cu, and Targeted Nutritional Cofactors on Bell’s Palsy Reversal in a Facial Nerve Crush Murine Model.docx (expert_opinion)Synergistic Effects of Thymosin Alpha-1, BPC-157, TB-500, LL-37, MOTS-c, SS-31, CJC-1295 with DAC, Ipamorelin, and Nicotine on Lyme Disease Reversal in a Borrelia burgdorferi-Infected Murine Model.docx (expert_opinion)Copy of Synergistic Effects of Monolaurin, Thymosin Alpha-1, KPV, SS-31, MOTS-c, Zinc, Vitamin D3, B12, Folate, Selenium, Magnesium Glycinate, and DGL on Epstein-Barr Virus Reversal in a Murine Gammaherpesvirus 68 (MHV-68) Model.docx (expert_opinion)
Dosing references are provider-only and shown in the asset evidence / protocol context, never patient-facing.
Protocol builder
Protocol plans
Provider workspace
Review & notes
Current status: in_progress